Correlation Between Denali Therapeutics and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Coya Therapeutics, Common, you can compare the effects of market volatilities on Denali Therapeutics and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Coya Therapeutics,.
Diversification Opportunities for Denali Therapeutics and Coya Therapeutics,
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Denali and Coya is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Coya Therapeutics,
Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Coya Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 1.68 times less risky than Coya Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Coya Therapeutics, Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 601.00 in Coya Therapeutics, Common on September 6, 2024 and sell it today you would earn a total of 8.00 from holding Coya Therapeutics, Common or generate 1.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Denali Therapeutics vs. Coya Therapeutics, Common
Performance |
Timeline |
Denali Therapeutics |
Coya Therapeutics, Common |
Denali Therapeutics and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and Coya Therapeutics,
The main advantage of trading using opposite Denali Therapeutics and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |